Single Cell Technology (SCT) has developed a truly unusual platform to identify and optimize antibodies for both therapeutics and diagnostics. We deliver in a single run thousands of unique antibodies, each carefully ranked based on kinetic properties and site binding characteristics. In addition, we obtain valuable insight into the molecular target's structure, information that was previously simply unavailable. As shown in the accompanying graph, the growth in antibody therapies and diagnostics places Single Cell at the nexus of contemporary medicine.